Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756379 · ClinicalTrials.gov registry record · NA
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease
A NA study of Coronary Artery Disease and Cardiovascular Disease, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- NA
- Development phase
- 1,085
- Enrollment target
- 1
- Study location
NCT00756379 is a NA study of Coronary Artery Disease and Cardiovascular Disease that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,085 participants, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00756379, a NA study of Coronary Artery Disease and Cardiovascular Disease, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,085 participants
- Enrollment target
- 1
- Study location
Study Summary
The Century Trial is a single center Phase III randomized study sponsored by the Albert Weatherhead III Foundation and conducted by Dr. K. Lance Gould. The study hypothesis is that a combined image-treatment regimen of PET + comprehensive program of lifestyle modification and lipid lowering drugs to target lipid level will result in an improved cardiovascular risk score when compared to current standard optimal medical therapy, potentially resulting in a lower rate of death, non-fatal myocardial infarction (MI) and revascularization procedures during long term follow-up when compared with current standard of care. If our hypothesis is correct, we will not only improve our ability to prevent and treat CAD but we will also illustrate that, even with the expenses of behavioral interventions and imaging techniques, we can be very cost effective. This information may help patients at risk or with known CAD to obtain insurance coverage to prevent the disease as well as providing a more effective way of treating it.
Conditions Studied
Interventions
- OTHER Comprehensive therapy program for risk factor modification
Study Locations (1)
Texas
- Weatherhead PET Center, Memorial Hermann Hospital TMC - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,085 participants |
| Start Date | 2009-03-11 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00756379
The ClinicalTrials.gov registry entry for NCT00756379 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,085 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (15% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive therapy program for risk factor modification is the first listed.
NCT00756379 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00756379 about?
NCT00756379 is a clinical study titled "Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease". The Century Trial is a single center Phase III randomized study sponsored by the Albert Weatherhead III Foundation and conducted by Dr. K. Lance Gould. The study hypothesis is that a combined image-treatment regimen of PET + comprehensive program of lifestyle modification and lipid lowering drugs to...
What is the current status of trial NCT00756379?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,085 participants. The study started on 2009-03-11. Estimated completion is 2027-05-31.
What conditions does trial NCT00756379 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Cardiovascular Disease, Atherosclerosis, Coronary Stenosis.
What interventions are being tested in trial NCT00756379?
The interventions under investigation include: Comprehensive therapy program for risk factor modification (OTHER).
Who is sponsoring clinical trial NCT00756379?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00756379 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.